Table 3. Laboratory features of hospitalized case-patients with confirmed severe fever with thrombocytopenia syndrome during the first week after onset, by outcome, South Korea, 2013*.
| Laboratory tests |
Median (range) |
p value† |
||
| Total, n = 32 |
Died, n = 14 |
Recovered, n = 18 |
||
| Platelet count, × 109/L‡ | 38 (15–113) | 34 (15–113) | 47.5 (29–107) | 0.054 |
| Leukocyte count, × 109 cells/L‡ | 1.5 (0.7–3.0) | 1.5 (0.7–3.0) | 1.5 (0.7–2.7) | 0.925 |
| ANC, × 106 cells/L, n = 30‡ | 969 (125–3,292) | 1,042 (380–2,367) | 920 (125–3,292) | 0.637 |
| Hemoglobin, g/L‡ | 12.9 (9.2–16.4) | 12.1 (9.2–15.1) | 13.5 (9.8–16.4) | 0.193 |
| aPTT, s, n = 30 | 54 (35–97) | 60 (35–97) | 54 (36–73) | 0.400 |
| AST, U/L, n = 31 | 242 (63–4,567) | 420 (103–4,567) | 223 (63–2,145) | 0.109 |
| ALT, U/L, n = 31 | 77 (27–1,432) | 156 (28–1,432) | 63 (27–477) | 0.186 |
| Total bilirubin, mg/dL, n = 31 | 0.5 (0.2–4.0) | 0.6 (0.3–4.0) | 0.5 (0.2–1.3) | 0.109 |
| Amylase, U/L, n = 26 | 84 (40–333) | 78 (49–163) | 90 (40–333) | 0.540 |
| Lipase, U/L, n = 20 | 98 (38–692) | 92 (38–369) | 117 (40–692) | 0.370 |
| CK, U/L, n = 21 | 570 (67–4,362) | 428 (158–4,362) | 676 (67–2,760) | 0.651 |
| CK-MB, U/L, n = 18 | 6.9 (0.3–300.0) | 4.8 (1.4–300.0) | 7.6 (0.3–35.0) | 0.762 |
| LDH, U/L, n = 28 | 908 (279–4,564) | 1,799 (279–4,564) | 893 (348–3,920) | 0.260 |
| ALP, U/L, n = 31 | 119 (44–1,586) | 213 (53–1,586) | 79 (44–510) | 0.017 |
*ANC, absolute neutrophil count; aPTT, activated partial thromboplastin time; AST, aspartate aminotransferase; ALT, alanine aminotransferase; CK, creatinine kinase; CK-MB, creatinine kinase myocardial b fraction; LDH, lactate dehydrogenase; ALP, alkaline phosphatase. †Mann-Whitney U test was used to compare groups. ‡Minimum value.